News & Views

  • CEO to Steer Growth in iPSC Markets
    Liam Taylor

CEO to Steer Growth in iPSC Markets

Oct 23 2020 Read 453 Times

Liam Taylor has been appointed CEO of Axol Bioscience, a developer of stem cell technology and cell-based assay systems for drug discovery, with a focus on maximizing team potential and the company’s iPSC (induced pluripotent stem cell) technologies, products and services.

Liam is a highly experienced senior executive with extensive knowledge of running commercial, operations, finance and innovation teams in the diagnostic, pharma and life science sector, both in the UK and US. Most recently he was CFO and then Managing Director of BBI Solutions, during which time the business’ annual revenues grew from £23M to over £52M, driven by organic growth and strategic acquisitions, which broadened the Company’s product and service offerings.

Dr Jonathan Milner, Chairman, Axol Bioscience, said: “The Board is delighted to appoint Liam as Axol’s new CEO. His wealth of experience and comprehensive knowledge of the pharma and life science sector will be invaluable in unlocking the full potential of the Company.”

“The progress achieved at Axol Bioscience in developing high quality and consistent iPSCs has been impressive, and I am excited to be joining at an exciting point in the Company’s development where we will be working to scale up operations to support the rapidly growing biotech and pharmaceutical markets, to support increases in efficiency within drug screening and discovery,” Mr Taylor added.

More information online

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment





Digital Edition

Lab Asia December 2020

December 2020

In This Edition Articles - The Movement Towards More Comprehensive Testing of Mycotoxins in Cannabis - Addressing proper HACCP implementation - Micropatterning: The art of micro-controlling...

View all digital editions

Events

CISILE 2020 - NEW DATES

Dec 08 2020 Beijing, China

PHAR-EAST - NEW DATES

Dec 08 2020 VIrtual event

Nano Tech 2021 - NEW DATES

Dec 09 2020 Tokyo, Japan

Medical Fair Asia 2020 - NEW DATES

Dec 09 2020 Virtual event

View all events